The G allele of MMP12 -82 A > G promoter polymorphism as a protective factor for COPD in Bulgarian population

References

• Arja, C., et al., 2014. Genetic determinants of chronic obstructive pulmonary disease in South Indian male smokers. PLoS One, 9, 2014.
   Web of Science ®Google Scholar
• Bidan, C.M., et al., 2015. Airway and Extracellular Matrix Mechanics in COPD. Frontiers in physiology, 6, 2015.
   Google Scholar
• Chung, K.F. and Adcock, I.M., 2008. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. The European respiratory journal, 31, 1334–1356.
   PubMed Web of Science ®Google Scholar
• Churg, A., et al., 2003. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. American journal of respiratory and critical care medicine, 167, 1083–1089.
   PubMed Web of Science ®Google Scholar
• Churg, A., et al., 2009. Expression of profibrotic mediators in small airways versus parenchyma after cigarette smoke exposure. American Journal of respiratory cell and molecular biology, 40, 268–276.
   PubMed Web of Science ®Google Scholar
• Demedts, I.K., et al., 2005. Matrix metalloproteinases in asthma and COPD. Current Opinion in Pharmacology, 5, 257–263.
   PubMed Web of Science ®Google Scholar
• Dimov, D., et al., 2013. Obesity in Bulgarian patients with chronic obstructive pulmonary disease. Chronic respiratory disease, 10, 215–222.
   PubMed Web of Science ®Google Scholar
• GOLD. 2017. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2017 report.
   Google Scholar
• Haq, I., et al., 2010. Association of MMP-12 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population. BMC medical genetics, 11, 1471–2350.
   Web of Science ®Google Scholar
• He, J., Turino, G.M., and Lin, Y.Y., 2010. Characterization of peptide fragments from lung elastin degradation in chronic obstructive pulmonary disease. Experimental lung research, 36, 548–557.
   PubMed Web of Science ®Google Scholar
• Heinz, A., et al., 2010. Degradation of tropoelastin by matrix metalloproteinases-cleavage site specificities and release of matrikines. The febs journal, 277, 1939–1956.
   PubMed Web of Science ®Google Scholar
• Hernandez-Montoya, J., et al., 2015. Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population. Biomarkers in medicine, 9, 979–988.
   PubMed Web of Science ®Google Scholar
• Hogg, J.C., et al., 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. The New England journal of medicine, 350, 2645–2653.
   PubMed Web of Science ®Google Scholar
• Hogg, J.C. and Senior, R.M., 2002. Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema. Thorax, 57, 830–834.
   PubMed Web of Science ®Google Scholar
• Houghton, a. M., 2015. Matrix metalloproteinases in destructive lung disease. Matrix biology, 46, 167–174.
   Web of Science ®Google Scholar
• Hunninghake, G.M., et al., 2009. MMP12, lung function, and COPD in high-risk populations. The New England journal of medicine, 361, 2599–2608.
   PubMed Web of Science ®Google Scholar
• Ishii, T., et al., 2014. Alveolar macrophage proteinase/antiproteinase expression in lung function and emphysema. The European respiratory journal, 43, 82–91.
   PubMed Web of Science ®Google Scholar
• Joos, L., et al., 2002. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Human molecular genetics, 11, 569–576.
   PubMed Web of Science ®Google Scholar
• Jormsjo, S., et al., 2000. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circulation research, 86, 998–1003.
   PubMed Web of Science ®Google Scholar
• Koppisetti, R.K., et al., 2014. Ambidextrous binding of cell and membrane bilayers by soluble matrix metalloproteinase-12. Nature communications, 5, 5552. doi:10.1038/ncomms6552.
   PubMed Web of Science ®Google Scholar
• Korytina, G.F., et al., 2008. Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients]. Russian journal of genetics, 44, 242–249.
   Web of Science ®Google Scholar
• Korytina, G.F., et al., 2012. Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease]. Molecular biology, 46, 487–499
   Web of Science ®Google Scholar
• Molet, S., et al., 2005. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflammation research, 54, 31–36.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, S., et al., 2010. Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults. Journal of allergy and clinical immunology, 126, 70–76.
   PubMed Web of Science ®Google Scholar
• Nenan, S., et al., 2005. Macrophage elastase (MMP-12): a pro-inflammatory mediator? Memórias do Instituto Oswaldo Cruz, 1, 167–172.
   Web of Science ®Google Scholar
• Pardo, A., et al., 2016. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respiratory research, 17, 016–0343.
   PubMed Web of Science ®Google Scholar
• Quanjer, P., 1984. Reference values for adolescents from ages 15 to 20. Schweiz Med Wochenschr, 114(43), 1507.
   PubMedGoogle Scholar
• Quanjer, P.H., Dalhuijsen, A., and B, V.Z., 1983. Standardized lung function testing. Report working party for the European Community for Coal and Steel. Bulletin Européen de physiopathologie respiratoire, 19, 1–95.
   PubMedGoogle Scholar
• Rabe, K.F., et al., 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOld executive summary. american journal of respiratory and critical care medicine, 176, 532–555.
   PubMed Web of Science ®Google Scholar
• Sand, J.M., et al., 2015. Accelerated extracellular matrix turnover during exacerbations of COPD. Respiratory research, 16, 015–0225.
   PubMed Web of Science ®Google Scholar
• Skjot-Arkil, H., et al., 2012. Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation. BMC pulmonary medicine, 12, 1471–2466.
   Web of Science ®Google Scholar
• Van Diemen, C.C., et al., 2011. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts. Respiratory research, 12, 1465–9921.
   Web of Science ®Google Scholar
• Visse, R. and Nagase, H., 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation research, 92, 827–839.
   PubMed Web of Science ®Google Scholar
• Wells, J.M., Gaggar, A., and Blalock, J.E., 2015. MMP generated matrikines. Matrix biology, 46, 122–129.
   Web of Science ®Google Scholar
• Westergren-Thorsson, G., Bjermer, L., and Hallgren, O., 2014. Extracellular matrix remodeling in COPD. European medical journal, NOVEMBER 19, 1--6.
   Google Scholar
• Westergren-Thorsson, G., et al., 2010. Pathological airway remodelling in inflammation. The clinical respiratory journal, Suppl 1, 1–8.
   Web of Science ®Google Scholar
• Zhang, R.B., et al., 2005. [Study on matrix metalloproteinase 1, 9, 12 polymorphisms and susceptibility to chronic obstructive pulmonary disease among Han nationality in northern China]. Zhonghua Liu Xing Bing Xue Za Zhi, 26, 907–910.
   PubMedGoogle Scholar
• Zhou, H., et al., 2013. Genetic polymorphism of matrix metalloproteinase family and chronic obstructive pulmonary disease susceptibility: a meta-analysis. Scientific reports, 3, 2818. doi:10.1038/srep02818.
   PubMed Web of Science ®Google Scholar